INFECTION AND HISTOPATHOLOGY IN PRETERM LABOR
INFECTION AND HISTOPATHOLOGY IN PRETERM LABOR
批准号:
3146905
负责人:
David Eschenbach
金额:
$24.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-09-01 至 1996-04-30
关键词:
Chlamydia trachomatis Lactobacillus Mycoplasma Streptococcus agalactiae amniocentesis amnion amniotic fluid antibacterial agents antibacterial antibody antibiotics bacterial disease chorioallantoic membrane disease /disorder proneness /risk endometrium female gas chromatography gestational age histology histopathology human pregnant subject human subject induced labor inflammation microorganism classification microorganism culture microorganism disease chemotherapy placenta pregnancy infection premature infant human premature labor serology /serodiagnosis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
There is evidence that afebrile women in premature labor can be
infected. Organisms are present in the amniotic fluid of 10% of
the women in premature labor. Organisms can be isolated from
between the chorion and amnion of 60% of the women who deliver
prematurely, in contrast to only 20% of women who deliver at
term.
The major objective of this study is to define the microbiology
and histopathology of women in premature labor and to treat the
women in premature labor with antibiotics. The specific aims
are: 1) define the vaginal/cervical, amniotic fluid and placental
microbiology of women in premature labor, 2) study selected
microbiologic factors associated with infection, 3) demonstrate
that antibiotics given to women in premature labor will reduce
premature deliveries compared to placebo treated women, 4)
demonstrate that placental and decidual inflammation is highly
correlated with both infection and preterm delivery, and 5)
evaluate defense mechanisms which may protect against
infection.
We plan to conduct a case-control study in which cases consisting
of afebrile women in premature labor with intact membranes will
undergo vaginal/cervical and trans-abdominal amniotic fluid
cultures. These women will be placed in a randomized double-
blinded trial of intravenous mezlocillin and oral erythromycin or
saline placebo. The control group will be stratified into women
who deliver at 34-37 and greater than 37 weeks of pregnancy.
After delivery, cultures of the chorion-amnion and histology of
the placental and endometrium will be performed. To evaluate
the effect of infection on pregnancy the presence of
vaginal/cervical, endometrial, placental membrane and amniotic
organisms and/or inflammation will be compared among 450
causes and 450 control women.
We will evaluate whether high organism concentration or
organism virulence will positively correlate with infection and
whether selected organisms, amniotic fluid bacterial inhibitory
factors and serum antibody will negatively correlate with
infection.
It is hoped that the result of these studies will demonstrate the
microbiology and pathophysiology of infection among women in
premature labor and that antibiotic therapy will reduce the rate
of premature births.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Women's Reproductive Health Research at the Univ of WA
-
批准号:8321592
-
项目类别:
-
资助金额:$47.34万
-
财政年份:1998
-
负责人:David Eschenbach
-
依托单位:
Women's Reproductive Health Research at the Univ of WA
-
批准号:6892116
-
项目类别:
-
资助金额:$24.99万
-
财政年份:1998
-
负责人:David Eschenbach
-
依托单位:
Women's Reproductive Health Research at the Univ of WA
-
批准号:8135531
-
项目类别:
-
资助金额:$4.0万
-
财政年份:1998
-
负责人:David Eschenbach
-
依托单位:
Women's Reproductive Health Research at the Univ of WA
-
批准号:7797147
-
项目类别:
-
资助金额:$47.34万
-
财政年份:1998
-
负责人:David Eschenbach
-
依托单位:
RESEARCH TRAINING CTR FOR PHYSICIANS IN WOMEN'S HEALTH
-
批准号:6476588
-
项目类别:
-
资助金额:$38.87万
-
财政年份:1998
-
负责人:David Eschenbach
-
依托单位:
RESEARCH TRAINING CTR FOR PHYSICIANS IN WOMEN'S HEALTH
-
批准号:6329788
-
项目类别:
-
资助金额:$38.87万
-
财政年份:1998
-
负责人:David Eschenbach
-
依托单位:
Women's Reproductive Health Research at the Univ of WA
-
批准号:6785739
-
项目类别:
-
资助金额:$24.99万
-
财政年份:1998
-
负责人:David Eschenbach
-
依托单位:
Women's Reproductive Health Research at the Univ of WA
-
批准号:7425796
-
项目类别:
-
资助金额:$34.88万
-
财政年份:1998
-
负责人:David Eschenbach
-
依托单位:
Women's Reproductive Health Research at the Univ of WA
-
批准号:8525410
-
项目类别:
-
资助金额:$47.34万
-
财政年份:1998
-
负责人:David Eschenbach
-
依托单位:
RESEARCH TRAINING CTR FOR PHYSICIANS IN WOMEN'S HEALTH
-
批准号:6625130
-
项目类别:
-
资助金额:$8.18万
-
财政年份:1998
-
负责人:David Eschenbach
-
依托单位:
Women's Reproductive Health Research at the Univ of WA
-
批准号:7942019
-
项目类别:
-
资助金额:$47.34万
-
财政年份:1998
-
负责人:David Eschenbach
-
依托单位:
Women's Reproductive Health Research at the Univ of WA
-
批准号:7087030
-
项目类别:
-
资助金额:$33.39万
-
财政年份:1998
-
负责人:David Eschenbach
-
依托单位:
Women's Reproductive Health Research at the Univ of WA
-
批准号:7282342
-
项目类别:
-
资助金额:$34.56万
-
财政年份:1998
-
负责人:David Eschenbach
-
依托单位:
INTRAVAGINAL PRODUCTS EFFECT ON VAGINAL PHYSIOLOGY
-
批准号:2206615
-
项目类别:
-
资助金额:$48.65万
-
财政年份:1995
-
负责人:David Eschenbach
-
依托单位:
INTRAVAGINAL PRODUCTS EFFECT ON VAGINAL PHYSIOLOGY
-
批准号:2889188
-
项目类别:
-
资助金额:$47.5万
-
财政年份:1995
-
负责人:David Eschenbach
-
依托单位:
INTRAVAGINAL PRODUCTS EFFECT ON VAGINAL PHYSIOLOGY
-
批准号:2403526
-
项目类别:
-
资助金额:$43.98万
-
财政年份:1995
-
负责人:David Eschenbach
-
依托单位:
INTRAVAGINAL PRODUCTS EFFECT ON VAGINAL PHYSIOLOGY
-
批准号:2673880
-
项目类别:
-
资助金额:$45.7万
-
财政年份:1995
-
负责人:David Eschenbach
-
依托单位:
INTRAVAGINAL PRODUCTS EFFECT ON VAGINAL PHYSIOLOGY
-
批准号:2206614
-
项目类别:
-
资助金额:$38.14万
-
财政年份:1995
-
负责人:David Eschenbach
-
依托单位:
HISTOPATHOLOGY AND ANTIBIOTIC THERAPY IN PREMATURE LABOR
-
批准号:3321601
-
项目类别:
-
资助金额:$23.74万
-
财政年份:1987
-
负责人:David Eschenbach
-
依托单位:
INFECTION AND HISTOPATHOLOGY IN PRETERM LABOR
-
批准号:3146906
-
项目类别:
-
资助金额:$24.95万
-
财政年份:1987
-
负责人:David Eschenbach
-
依托单位:
国内基金
海外基金
登录
查看更多内容
瘤内细菌 Lactobacillus iners 通过
eIF4A2 乳酸化介导肿瘤相关巨噬细胞极
化诱导膀胱癌免疫化疗抵抗的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:吴志明
-
依托单位:
肠道菌群Lactobacillus来源的吲哚-3-
甲醛对绝经后骨量丢失的保护机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:庄景燊
-
依托单位:
Lactobacillus reuteri调控FTO/CMPK2/NLRP3信号轴介导炎症反应治疗5-FU诱导的口腔粘膜炎的作用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邱敬诚
-
依托单位:
葛根交泰丸调控Lactobacillus介导胆汁酸“肠-肝轴”途径治疗2型糖尿病的机制研究
-
批准号:82305009
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王文波
-
依托单位:
草苁蓉介导的肠道Lactobacillus reuteri菌通过长链脂肪酸调控糖脂代谢改善2型糖尿病的作用机制
-
批准号:32260026
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:全林虎
-
依托单位:
Lactobacillus plantarum CQPC05通过细胞凋亡通路干预结直肠癌的效果
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:余婷
-
依托单位:
基于肠道菌群-免疫轴解析Lactobacillus murinus 0516抗鸡传染性支气管炎病毒感染的机制
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:尹海畅
-
依托单位:
荔枝黄酮QRR与原花青素A2协同增殖肠道Akkermansia和Lactobacillus菌保护肠粘膜屏障机理研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:苏东晓
-
依托单位:
猪肠道细菌Lactobacillus gasseri LA39调控胆汁酸代谢的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位:
益生菌Lactobacillus plantarum HNU082在宿主肠道内适应性进化机制研究
-
批准号:32160545
-
项目类别:地区科学基金项目
-
资助金额:36万元
-
批准年份:2021
-
负责人:张家超
-
依托单位: